How to buy Incannex Healthcare (IHL) shares in Australia
Learn how to easily invest in Incannex Healthcare shares.
Incannex Healthcare is a drug manufacturers - specialty & generic business based in Australia. Incannex Healthcare shares (IHL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Incannex Healthcare has a trailing 12-month revenue of around $1 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Incannex Healthcare
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Incannex Healthcare. Find the share by name or ticker symbol: IHL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Incannex Healthcare reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Incannex Healthcare. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
What's in this guide?
- Incannex Healthcare key stats
- Compare share trading platforms
- Is Incannex Healthcare stock a buy or sell?
- Incannex Healthcare performance over time
- Incannex Healthcare's financials
- How volatile are Incannex Healthcare shares?
- Does Incannex Healthcare pay a dividend?
- Have Incannex Healthcare shares ever split?
- Other common questions
Incannex Healthcare stock price (ASX:IHL)Use our graph to track the performance of IHL stocks over time.
Incannex Healthcare shares at a glance
|52-week range||$0.041 - $0.24|
|50-day moving average||$0.0595|
|200-day moving average||$0.0988|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.3|
Compare share trading platforms
Is it a good time to buy Incannex Healthcare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Incannex Healthcare price performance over time
|1 week (2023-11-23)||0.041|
|1 month (2023-11-03)||-39.71%|
|3 months (2023-09-01)||-51.76%|
|6 months (2023-06-02)||-62.73%|
|1 year (2022-12-02)||-82.17%|
|2 years (2021-12-03)||-92.26%|
|3 years (2020-12-03)||-71.72%|
|5 years (2018-12-03)||78.26%|
Incannex Healthcare financials
|Revenue TTM||$1 million|
|Gross profit TTM||$1 million|
|Return on assets TTM||-17.5%|
|Return on equity TTM||-33.3%|
|Market capitalisation||$92 million|
TTM: trailing 12 months
Incannex Healthcare share dividends
We're not expecting Incannex Healthcare to pay a dividend over the next 12 months.
Have Incannex Healthcare's shares ever split?
Incannex Healthcare's shares were split on a 1:20 basis on 29 July 2016. So if you had owned 20 shares the day before the split, the next day you would own 1 share. This wouldn't directly have changed the overall worth of your Incannex Healthcare shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Incannex Healthcare shares which in turn could have impacted Incannex Healthcare's share price.
Incannex Healthcare share price volatility
Over the last 12 months, Incannex Healthcare's shares have ranged in value from as little as $0.041 up to $0.24. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Incannex Healthcare's is 2.088. This would suggest that Incannex Healthcare's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Incannex Healthcare overview
Incannex Healthcare Limited, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies in Australia. The company offers APIRx-1801, an ultrapure tetrahydrocannabinol; APIRx-1802, an ultrapure CBD; and APIRx-1803, an ultrapure cannabigerol. It also develops IHL-42X, which has completed Phase IIb clinical trial for obstructive sleep apnea; Psi-GAD that is in Phase IIa clinical trial for generalized anxiety disorder; MedChew Dronabinol, which has completed Phase Ia clinical trial for nausea and vomiting in chemotherapy; CanChew Plus that has completed Phase IIa clinical trial for irritable bowel syndrome; APIRx-1601, which has completed Phase IIa clinical trial for vitiligo; APIRx-1602 skin that has completed Phase IIa clinical trial for psoriasis; and APIRx-1603, which has completed Phase IIa clinical trial for atopic dermatitis. In addition, its product portfolio includes IHL-675A for inflammatory lung disease, IHL-675A for rheumatoid arthritis, IHL-675A for inflammatory bowel disease, and IHL-216A for traumatic brain injury and concussion, which have completed pre-clinical trials; and MedChew 1401 for pain and spasticity in multiple sclerosis, MedChew GB for post-herpatic neuralgia, MedChew-1502 for Parkinson's disease, MedChew-1503 for dementia, MedChew RL for restless legs syndrome, APIRx 1505 Flotex for chrohn's disease, CanChew RX and SuppoCan (Suppository) for inflammatory bowel disease, CheWell for addiction of cannabis, CanQuit for tobacco smoking cessation, CanQuit O for opioid addiction, APIRx-1701 for glaucoma, suppoCan gastro for IBD, and APIRx-1702 for dry eye syndrome that are in pre-clinical trials. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Docklands, Australia.
Stocks similar to Incannex Healthcare
Incannex Healthcare in the news
Frequently asked questions
More guides on Finder
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert